Treatment Options Post Exposure to COVID-19

Introductory content goes here…

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris placerat ullamcorper sem eu sodales. Praesent suscipit mauris nec augue bibendum, ut consequat massa sodales. Proin et lacus enim. Vivamus vulputate luctus ultrices. Quisque consequat porttitor fringilla. Mauris vitae nulla porttitor, gravida diam et, egestas mauris. Mauris convallis metus at urna rutrum, eget hendrerit metus porttitor. Maecenas posuere lorem rhoncus nisi eleifend mollis. 

Web Tip: This has the potential to change everything and give us freedom like that already enjoyed by those vaccinated who have a normal immune system.

CLL and COVID-19: Light at the End of the Tunnel?

Dr. Koffman interviewed the lead researcher, Dr. Carsten Niemann, Associate Professor of Hematology at the University of Copenhagen. Dr. Niemann shared encouraging news and a brighter outlook for those of us with CLL in this interview I hope you will enjoy.

ASH 2021: Dr. Jake Soumerai on the Immune Response to COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia (CLL)

At the American Society of Hematology (ASH) 2021, our own Dr. Brian Koffman interviewed Dr. Jake Soumerai, a clinical investigator at Massachusetts General Hospital and an Assistant Professor at Harvard Medical School. They discussed some new research that looked at the immune response to COVID-19 vaccination in patients with CLL more comprehensively than just antibody levels.

Update to the FDA Fact Sheet for Healthcare Providers: Emergency Use Authorization for Evusheld

On October 3, 2022, the FDA updated the guidance offered to healthcare providers concerning Evusheld (the cocktail of two COVID-19 monoclonal antibodies, tixagevimab, and cilgavimab). Evusheld which is currently the only authorized  Pre-Exposure Prophylaxis (PrEP) against COVID-19 for the immunocompromised, including those with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), in whom protection provided by the COVID-19 vaccine is unpredictable and less robust.